Webinars

Search

Saved Activities

 x 

0 Activities
0 Activities

Considering Biosimilars in Patients Failing their Initial Biologic

Array

Activity Info

Upon completion of the activity, participants should be able to explain the circumstances under which it is appropriate to initiate or switch a patient with a rheumatologic disease to a biosimilar.
Email

CME/CE credit is no longer available for this activity.

Tags

Webinar | 0.25 - 15 mins | Internal Medicine | Rheumatology | Family Medicine | Nurse | Biosimilars | BiosimilarsCME.org | Online | Pharmacist |